FDA acting chief grilled over appointment, ties to predecessor
The acting chief of the Philippines' Food and Drug Administration (FDA) faced tough questioning from a senator regarding his appointment and alleged irregularities in his rise, linked to his predecessor. The senator pointed out that the acting chief was appointed over more experienced personnel.
This article requires PRO
This article is outside the free access window or is a special report. PRO unlocks it and the full archive.
Related articles
- Philippines' Tanduay Rum Showcases Heritage at Bar Convent Berlin
Philippine rum brand Tanduay showcased its heritage and craftsmanship at Bar Convent Berlin, a leading global trade fair for the bar and beverage industries. The company aimed to boost brand recognition and explore market opportunities in Europe by unveiling a 20-year-old reserve rum and hosting masterclasses.
- Petron Net Income Down 44% to P5.4 Billion Amid Middle East Conflict
Petron Corp., the Philippines' leading oil refiner and marketer, reported a 44% year-on-year drop in net income to P5.4 billion for the January-September period. The decline is attributed to the prolonged conflict in the Middle East, which impacted refinery operations and crude oil prices.
- BSP Signals Rate Cuts Distant Amid Persistent Inflation
Bangko Sentral ng Pilipinas (BSP) Governor Eli Remolona Jr. indicated that while the economy may have begun recovering in the third quarter, interest rate cuts are likely still distant due to persistently high inflation expectations. GDP growth is anticipated, but price pressures are tempering monetary easing.
- Moody’s: PH Sustainable Bond Market to Grow on Infra, Energy Shift
Moody's Ratings forecasts growth in the Philippines' sustainable bond market, driven by infrastructure development and energy transition. Rising investor demand for strong governance, transparency, and clear commitments on fund usage underpins this outlook. The Philippines holds the third-largest market in Southeast Asia.